img

Global SARS-CoV-2 IgG (RBD) ELISA Market Segment Research Report 2024

Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global SARS-CoV-2 IgG (RBD) ELISA Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global SARS-CoV-2 IgG (RBD) ELISA Market Segment Research Report 2022》, which aims to sort out the development status and trends of the SARS-CoV-2 IgG (RBD) ELISA industry at home and abroad, estimate the overall market scale of the SARS-CoV-2 IgG (RBD) ELISA industry and the market share of major countries, SARS-CoV-2 IgG (RBD) ELISA industry, and study and judge the downstream market demand of SARS-CoV-2 IgG (RBD) ELISA through systematic research, Analyze the competition pattern of SARS-CoV-2 IgG (RBD) ELISA, so as to help solve the pain points of various stakeholders in SARS-CoV-2 IgG (RBD) ELISA industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of SARS-CoV-2 IgG (RBD) ELISA Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in SARS-CoV-2 IgG (RBD) ELISA Market?
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
LOEWE Biochemica
Shenzhen YHLO Biotech
LG
Major Type of SARS-CoV-2 IgG (RBD) ELISA Covered in XYZResearch report
ELISA Sets
ELISA Kits
Application Segments Covered in XYZResearch Market
Hospital
Clinic
Disease control and prevention system

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global SARS-CoV-2 IgG (RBD) ELISA Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global SARS-CoV-2 IgG (RBD) ELISA Market by Value
2.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Type
2.2.2 Global SARS-CoV-2 IgG (RBD) ELISA Market by Value (%)
2.3 Global SARS-CoV-2 IgG (RBD) ELISA Market by Production
2.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Production by Type
2.3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market by Production (%)

3. The Major Driver of SARS-CoV-2 IgG (RBD) ELISA Industry
3.1 Historical & Forecast Global SARS-CoV-2 IgG (RBD) ELISA Demand
3.2 Largest Application for SARS-CoV-2 IgG (RBD) ELISA (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional SARS-CoV-2 IgG (RBD) ELISA Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of SARS-CoV-2 IgG (RBD) ELISA Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global SARS-CoV-2 IgG (RBD) ELISA Average Price Trend
12.1 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in US (2018-2022)
12.2 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Europe (2018-2022)
12.3 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in China (2018-2022)
12.4 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Japan (2018-2022)
12.5 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in India (2018-2022)
12.6 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Korea (2018-2022)
12.7 Market Price for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 SARS-CoV-2 IgG (RBD) ELISA Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of SARS-CoV-2 IgG (RBD) ELISA

14. SARS-CoV-2 IgG (RBD) ELISA Competitive Landscape
14.1 R&D Systems
14.1.1 R&D Systems Company Profiles
14.1.2 R&D Systems Product Introduction
14.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Thermo Fisher Scientific
14.2.1 Thermo Fisher Scientific Company Profiles
14.2.2 Thermo Fisher Scientific Product Introduction
14.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Ortho Clinical Diagnostics
14.3.1 Ortho Clinical Diagnostics Company Profiles
14.3.2 Ortho Clinical Diagnostics Product Introduction
14.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 BD Biosciences
14.4.1 BD Biosciences Company Profiles
14.4.2 BD Biosciences Product Introduction
14.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 ZEUS Scientific
14.5.1 ZEUS Scientific Company Profiles
14.5.2 ZEUS Scientific Product Introduction
14.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Bio-Rad Laboratories
14.6.1 Bio-Rad Laboratories Company Profiles
14.6.2 Bio-Rad Laboratories Product Introduction
14.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 ALPCO
14.7.1 ALPCO Company Profiles
14.7.2 ALPCO Product Introduction
14.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Enzo Life Sciences
14.8.1 Enzo Life Sciences Company Profiles
14.8.2 Enzo Life Sciences Product Introduction
14.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 BioMérieux
14.9.1 BioMérieux Company Profiles
14.9.2 BioMérieux Product Introduction
14.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 LOEWE Biochemica
14.10.1 LOEWE Biochemica Company Profiles
14.10.2 LOEWE Biochemica Product Introduction
14.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Shenzhen YHLO Biotech
14.12 LG
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of SARS-CoV-2 IgG (RBD) ELISA Industry (Volume)
Figure 2. SARS-CoV-2 IgG (RBD) ELISA Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2022
Figure 5. US SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. SARS-CoV-2 IgG (RBD) ELISA Revenue, by Type (Million USD) (2018-2028)
Table 4. SARS-CoV-2 IgG (RBD) ELISA Production, by Type (K Unit) (2018-2028)
Table 5. SARS-CoV-2 IgG (RBD) ELISA Demand (K Unit) by Application (2018-2028)
Table 6. SARS-CoV-2 IgG (RBD) ELISA Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top SARS-CoV-2 IgG (RBD) ELISA Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of SARS-CoV-2 IgG (RBD) ELISA in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. R&D Systems Profiles
Table 61. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 62. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. R&D Systems Strategic initiatives
Table 64. Thermo Fisher Scientific Profiles
Table 65. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 66. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Thermo Fisher Scientific Strategic initiatives
Table 68. Ortho Clinical Diagnostics Profiles
Table 69. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 70. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Ortho Clinical Diagnostics Strategic initiatives
Table 72. BD Biosciences Profiles
Table 73. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 74. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. BD Biosciences Strategic initiatives
Table 76. ZEUS Scientific Profiles
Table 77. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 78. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. ZEUS Scientific Strategic initiatives
Table 80. Bio-Rad Laboratories Profiles
Table 81. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 82. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bio-Rad Laboratories Strategic initiatives
Table 84. ALPCO Profiles
Table 85. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 86. ALPCO SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. ALPCO Strategic initiatives
Table 88. Enzo Life Sciences Profiles
Table 89. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 90. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Enzo Life Sciences Strategic initiatives
Table 92. BioMérieux Profiles
Table 93. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 94. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. BioMérieux Strategic initiatives
Table 97. LOEWE Biochemica Profiles
Table 98. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 99. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. LOEWE Biochemica Strategic initiatives
Table 101. Shenzhen YHLO Biotech Profiles
Table 102. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 103. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Shenzhen YHLO Biotech Strategic initiatives
Table 105. LG Profiles
Table 106. LG SARS-CoV-2 IgG (RBD) ELISA Product Introduction
Table 107. LG SARS-CoV-2 IgG (RBD) ELISA Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. LG Strategic initiatives

Select User License

$4850 Single Licence
$5850 Enterprise Licence
$6850 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries